BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-689@pharmaconomics
DTSTAMP:20260707T033829Z
DTSTART;VALUE=DATE:20260401
DTEND;VALUE=DATE:20260402
SUMMARY:LPCN Phase 3 — LPCN 1154
DESCRIPTION:Phase 3 trial results for LPCN 1154 in postpartum depression are due Apr 1\, 2026. A clean hit validates the program\; a miss can gap the stock down hard.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/1535955/000149315226002785/ex99-1.htm\n\nTrack it: https://pharmaconomics.com/e/689
URL:https://pharmaconomics.com/e/689
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:LPCN catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR